ID   APOE_BOVIN              Reviewed;         316 AA.
AC   Q03247; Q3T006; Q5E967;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   10-FEB-2021, entry version 140.
DE   RecName: Full=Apolipoprotein E;
DE            Short=Apo-E;
DE   Flags: Precursor;
GN   Name=APOE;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8422503; DOI=10.1007/bf00364665;
RA   Brzozowska A., Fries R., Womack J.E., Grimholt U., Myklebost O., Rogne S.;
RT   "Isolation, sequencing, and expression analysis of a bovine apolipoprotein
RT   E (APOE) cDNA and chromosomal localization of the APOE locus.";
RL   Mamm. Genome 4:53-57(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1908018; DOI=10.1007/bf02102649;
RA   Yang Y.W., Chan L., Li W.H.;
RT   "Cloning and sequencing of bovine apolipoprotein E complementary DNA and
RT   molecular evolution of apolipoproteins E, C-I, and C-II.";
RL   J. Mol. Evol. 32:469-475(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16305752; DOI=10.1186/1471-2164-6-166;
RA   Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L.,
RA   Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.;
RT   "Characterization of 954 bovine full-CDS cDNA sequences.";
RL   BMC Genomics 6:166-166(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Testis;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   GLYCOSYLATION AT THR-32; THR-211; THR-309 AND SER-310, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=19674964; DOI=10.1074/mcp.m900211-mcp200;
RA   Darula Z., Medzihradszky K.F.;
RT   "Affinity enrichment and characterization of mucin core-1 type
RT   glycopeptides from bovine serum.";
RL   Mol. Cell. Proteomics 8:2515-2526(2009).
CC   -!- FUNCTION: APOE is an apolipoprotein, a protein associating with lipid
CC       particles, that mainly functions in lipoprotein-mediated lipid
CC       transport between organs via the plasma and interstitial fluids. APOE
CC       is a core component of plasma lipoproteins and is involved in their
CC       production, conversion and clearance. Apoliproteins are amphipathic
CC       molecules that interact both with lipids of the lipoprotein particle
CC       core and the aqueous environment of the plasma. As such, APOE
CC       associates with chylomicrons, chylomicron remnants, very low density
CC       lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but
CC       shows a preferential binding to high-density lipoproteins (HDL). It
CC       also binds a wide range of cellular receptors including the LDL
CC       receptor/LDLR and the very low-density lipoprotein receptor/VLDLR that
CC       mediate the cellular uptake of the APOE-containing lipoprotein
CC       particles. Finally, APOE has also a heparin-binding activity and binds
CC       heparan-sulfate proteoglycans on the surface of cells, a property that
CC       supports the capture and the receptor-mediated uptake of APOE-
CC       containing lipoproteins by cells. {ECO:0000250|UniProtKB:P02649}.
CC   -!- SUBUNIT: Homotetramer. May interact with ABCA1; functionally associated
CC       with ABCA1 in the biogenesis of HDLs. May interact with APP/A4 amyloid-
CC       beta peptide; the interaction is extremely stable in vitro but its
CC       physiological significance is unclear. May interact with MAPT. May
CC       interact with MAP2. In the cerebrospinal fluid, interacts with secreted
CC       SORL1. {ECO:0000250|UniProtKB:P02649}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P02649}.
CC       Secreted, extracellular space {ECO:0000250|UniProtKB:P02649}. Secreted,
CC       extracellular space, extracellular matrix
CC       {ECO:0000250|UniProtKB:P02649}. Note=In the plasma, APOE is associated
CC       with chylomicrons, chylomicrons remnants, VLDL, LDL and HDL
CC       lipoproteins. Lipid poor oligomeric APOE is associated with the
CC       extracellular matrix in a calcium- and heparan-sulfate proteoglycans-
CC       dependent manner. Lipidation induces the release from the extracellular
CC       matrix. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: APOE exists as multiple glycosylated and sialylated glycoforms
CC       within cells and in plasma. The extent of glycosylation and sialylation
CC       are tissue and context specific. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Glycated in plasma VLDL. {ECO:0000250|UniProtKB:P02649}.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000250|UniProtKB:P02649}.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A1/A4/E family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X64839; CAA46051.1; -; mRNA.
DR   EMBL; X61171; CAA43479.1; -; mRNA.
DR   EMBL; BT021053; AAX09070.1; -; mRNA.
DR   EMBL; BC102620; AAI02621.1; -; mRNA.
DR   PIR; I45996; I45996.
DR   PIR; S26478; S26478.
DR   RefSeq; NP_776416.1; NM_173991.2.
DR   SMR; Q03247; -.
DR   STRING; 9913.ENSBTAP00000013354; -.
DR   GlyConnect; 813; 2 O-Linked glycans (4 sites).
DR   iPTMnet; Q03247; -.
DR   PaxDb; Q03247; -.
DR   PeptideAtlas; Q03247; -.
DR   PRIDE; Q03247; -.
DR   GeneID; 281004; -.
DR   KEGG; bta:281004; -.
DR   CTD; 348; -.
DR   eggNOG; ENOG502QVD6; Eukaryota.
DR   HOGENOM; CLU_066029_0_0_1; -.
DR   InParanoid; Q03247; -.
DR   OrthoDB; 1314660at2759; -.
DR   TreeFam; TF334458; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0042627; C:chylomicron; IEA:UniProtKB-KW.
DR   GO; GO:0031012; C:extracellular matrix; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0034364; C:high-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034363; C:intermediate-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034362; C:low-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; ISS:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; ISS:UniProtKB.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; ISS:UniProtKB.
DR   GO; GO:0070326; F:very-low-density lipoprotein particle receptor binding; IBA:GO_Central.
DR   GO; GO:0006707; P:cholesterol catabolic process; IBA:GO_Central.
DR   GO; GO:0033344; P:cholesterol efflux; ISS:UniProtKB.
DR   GO; GO:0034382; P:chylomicron remnant clearance; ISS:UniProtKB.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; ISS:UniProtKB.
DR   GO; GO:0071831; P:intermediate-density lipoprotein particle clearance; ISS:UniProtKB.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0042159; P:lipoprotein catabolic process; IBA:GO_Central.
DR   GO; GO:1905907; P:negative regulation of amyloid fibril formation; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IBA:GO_Central.
DR   GO; GO:1900223; P:positive regulation of amyloid-beta clearance; ISS:UniProtKB.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IBA:GO_Central.
DR   GO; GO:1900221; P:regulation of amyloid-beta clearance; IBA:GO_Central.
DR   GO; GO:0071830; P:triglyceride-rich lipoprotein particle clearance; ISS:UniProtKB.
DR   GO; GO:0034447; P:very-low-density lipoprotein particle clearance; ISS:UniProtKB.
DR   InterPro; IPR000074; ApoA_E.
DR   Pfam; PF01442; Apolipoprotein; 1.
PE   1: Evidence at protein level;
KW   Chylomicron; Extracellular matrix; Glycoprotein; HDL; Heparin-binding;
KW   Lipid transport; Lipid-binding; Oxidation; Phosphoprotein;
KW   Reference proteome; Repeat; Secreted; Signal; Transport; VLDL.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..316
FT                   /note="Apolipoprotein E"
FT                   /id="PRO_0000001984"
FT   REPEAT          79..100
FT                   /note="1"
FT   REPEAT          101..122
FT                   /note="2"
FT   REPEAT          123..144
FT                   /note="3"
FT   REPEAT          145..166
FT                   /note="4"
FT   REPEAT          167..188
FT                   /note="5"
FT   REPEAT          189..210
FT                   /note="6"
FT   REPEAT          211..232
FT                   /note="7"
FT   REPEAT          233..254
FT                   /note="8"
FT   REGION          79..254
FT                   /note="8 X 22 AA approximate tandem repeats"
FT   REGION          157..167
FT                   /note="LDL and other lipoprotein receptors binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          161..164
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          209..289
FT                   /note="Lipid-binding and lipoprotein association"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          228..235
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          265..316
FT                   /note="Homooligomerization"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   REGION          277..289
FT                   /note="Specificity for association with VLDL"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   MOD_RES         142
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250|UniProtKB:P08226"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02649"
FT   CARBOHYD        32
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:19674964"
FT   CARBOHYD        211
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:19674964"
FT   CARBOHYD        309
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:19674964"
FT   CARBOHYD        310
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:19674964"
FT   CONFLICT        129..130
FT                   /note="RN -> CG (in Ref. 2; CAA43479)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="P -> R (in Ref. 3; AAX09070 and 4; AAI02621)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   316 AA;  35980 MW;  1231292FC8DA9F1E CRC64;
     MKVLWVAVVV ALLAGCQADM EGELGPEEPL TTQQPRGKDS QPWEQALGRF WDYLRWVQTL
     SDQVQEELLN TQVIQELTAL MEETMKEVKA YKEELEGQLG PMAQETQARV SKELQAAQAR
     LGSDMEDLRN RLAQYRSEVQ AMLGQSTEEL RARMASHLRK LPKRLLRDAD DLKKRLAVYQ
     AGASEGAERS LSAIRERFGP LVEQGQSRAA TLSTLAGQPL LERAEAWRQK LHGRLEEVGV
     RAQDRLDKIR QQLEEVHAKV EEQGNQMRLQ AEAFQARLRS WFEPLVEDMQ RQWAGLVEKV
     QLALRPSPTS PPSENH
//
